Boxer Capital Healthcare News

This is selected healthcare news for Boxer Capital, which is filed under Capital Firms. There are 575 news items for this page. Boxer Capital is occasionally combined with Medivation, Encoded Therapeutics and XtalPi in news items.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/22/2022 Theseus Pharmaceuticals (NASDAQ:THRX) Trading Up 0.3%
... average price of $7.31 and a 200-day moving average price of $8.31. Institutional Trading of Theseus Pharmaceuticals Several hedge funds and other institutional investors have recently bought and sold shares of THRX. Boxer Capital LLC purchased a new stake in Theseus Pharmaceuticals during the 4th quarter valued at $11,311,000 ...
etfdailynews.com
9/7/2022 SpringWorks Therapeutics Announces $225 Million Private
... offering expenses. The closing of the financing is expected to occur on September 9, 2022, subject to customary closing conditions. The Financing includes participation from new and existing institutional investors, including EcoR1 Capital, Boxer Capital, Invus, Deerfield Management, Perceptive Advisors, and another large institutional investor. Goldman Sachs & Co. LLC acted ...
Globe Newswire
9/7/2022 SpringWorks Therapeutics Announces $225 Million Private Placement Financing
... offering expenses. The closing of the financing is expected to occur on September 9, 2022, subject to customary closing conditions. The Financing includes participation from new and existing institutional investors, including EcoR1 Capital, Boxer Capital, Invus, Deerfield Management, Perceptive Advisors, and another large institutional investor. Goldman Sachs & Co. LLC acted ...
Yahoo News
9/7/2022 (SWTX) – SpringWorks Therapeutics Announces $225 Million Private Placement Financing – Press Release
... offering expenses. The closing of the financing is expected to occur on September 9, 2022, subject to customary closing conditions. The Financing includes participation from new and existing institutional investors, including EcoR1 Capital, Boxer Capital, Invus, Deerfield Management, Perceptive Advisors, and another large institutional investor. Goldman Sachs & Co. LLC acted ...
wiredprnews.com
9/7/2022 SpringWorks Therapeutics (SWTX) SpringWorks Therapeutics Announces $225 Million Private Placement Financing
... offering expenses. The closing of the financing is expected to occur on September 9, 2022, subject to customary closing conditions. The Financing includes participation from new and existing institutional investors, including EcoR1 Capital, Boxer Capital, Invus, Deerfield Management, Perceptive Advisors, and another large institutional investor. Goldman Sachs & Co. LLC acted ...
researchpool.com
9/7/2022 SpringWorks Therapeutics Announces $225 Million Private Placement Financing biotechwinners.com
9/5/2022 Integral Health Asset Management LLC Purchases Shares of 50,000 PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - The Cerbat Gem thecerbatgem.com
9/3/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by Handelsbanken Fonder AB etfdailynews.com
8/31/2022 Healthcare of Ontario Pension Plan Trust Fund Makes New Investment in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) rivertonroll.com
8/25/2022 Here's what the hottest hedge funds are buying and selling news7f.com
8/25/2022 Here's what the hedge funds with the hottest hands are buying and selling - The New York Folk newyorkfolk.com
8/23/2022 New York State Common Retirement Fund Increases Stock Holdings in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) American Banking News
8/23/2022 New York State Common Retirement Fund Increases Stock Holdings in Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) defenseworld.net
8/23/2022 10,517 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Purchased by New York State Common Retirement Fund defenseworld.net
7/25/2022 Flare Therapeutics Appoints Amit Rakhit, M.D. as President and Chief Executive Officer Business Wire
7/25/2022 Flare Therapeutics Appoints Amit Rakhit, M.D. as President and Chief Executive Officer | Business | Maryville Daily Forum maryvilleforum.com
7/25/2022 Flare Therapeutics Appoints Amit Rakhit, M.D. as President and Chief Executive Officer | News | bakersfield.com bakersfield.com
6/17/2022 : Centessa Pharmaceuticals started at outperform with $19 stock price target at BMO Capital MarketWatch
6/8/2022 D. E. Shaw & Co. Inc. Cuts Stock Position in Blueprint Medicines Co. (NASDAQ:BPMC) zolmax.com
6/5/2022 Commodore Capital LP Purchases New Shares in BELLUS Health Inc. (NASDAQ:BLU) - Transcript Daily transcriptdaily.com
6/5/2022 Commodore Capital LP Purchases New Shares in BELLUS Health Inc. (NASDAQ:BLU) dispatchtribunal.com
6/4/2022 Power Corp of Canada Invests $39.73 Million in BELLUS Health Inc. (NASDAQ:BLU) rivertonroll.com
6/4/2022 Power Corp of Canada Invests $39.73 Million in BELLUS Health Inc. (NASDAQ:BLU) - Mayfield Recorder Mayfield Recorder
6/3/2022 Relay Therapeutics, Inc. (NASDAQ:RLAY) Shares Sold by PDT Partners LLC - Transcript Daily transcriptdaily.com
6/3/2022 Virtus ETF Advisers LLC Purchases 922 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Stock Observer thestockobserver.com